postibrutinib 1
outcomes 1
patients 1
mantle 1
cell 3
lymphoma 3
targeting 1
b 2
receptor 1
signaling 1
ibrutinib 1
diffuse 1
large 1
acr 1
appropriateness 1
criteria 1
followup 1
hodgkin 1
